Market Size of Europe Mass Spectrometry Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Historical Data Period | 2019 - 2022 |
CAGR | 6.50 % |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe Mass Spectroscopy Market Analysis
The Europe mass spectroscopy market is expected to register a CAGR of 6.5% over the forecast period.
Mass spectroscopy devices are mainly used in research and development activities in different industrial areas such as pharmaceuticals, life sciences, food, and others. As there were lockdown restrictions around the world due to the COVID-19 pandemic, these activities were negatively impacted and thus affected the mass spectrometry market. Mass spectrometry devices were used in the detection and analysis of COVID-19 samples which had a considerable positive impact on the market studied. For instance, an article by a journal, namely Healthcare in Europe, published in November 2020, mentioned that the United Kingdom biotech laboratory used mass spectroscopy in an approach to Coronavirus testing. In addition, MAP Sciences developed a gargle test, which collects samples from the back of the throat, and avoids the unpleasant sensation of the PCR swab tests. From there, the sample is tested for COVID testing mass spectroscopy with high levels of accuracy. Thus COVID-19 had a mixed impact on the growth of the market during the pandemic period. However, currently, the market has reached its pre-pandemic state in terms of the use of mass spectroscopy devices and is expected to witness healthy growth over the forecast period.
Key factors propelling the market growth include technological advancements and increased pharmaceutical and biotechnological compounds in the pipeline. Technological advancements in mass spectrometry are enabling new product launches from key players. For instance, in June 2022, Shimadzu introduced new mass spectrometers in the global market. Additionally, in June 2022, Agilent Technologies Inc. announced new LC/MS and GC/MS quadrupole mass spectrometers in the global market. The Agilent 6475 triple quadrupole LC/MS system, 5977C GC/MSD, plus the 7000E GC/TQ and the 7010C GC/TQ represent the latest revolution in Agilent's 50-plus year history in mass spectrometry.
In addition, in April 2021, bioMérieux, a French company, announced the CE-marking of the new MALDI-TOF mass spectrometry identification system, VITEK MS PRIME, in the European market. With the new launch of mass spectrometry by key European companies such as bioMerieux and Agilent Technologies, the market studied is believed to witness strong growth in coming years.
Thus the above-mentioned factors are expected to drive the demand during the forecast period in Europe. However, the lack of skilled technicians and the high cost of mass spectrometry equipment are restraining the market growth.
Europe Mass Spectroscopy Industry Segmentation
As per the scope of the report, mass spectroscopy is an analytical chemistry technique used to identify the amount and type of chemical species present in a sample by measuring the mass-to-charge ratio and abundance of gas-phase ions. The scope of the report includes the details of different technology in terms of market importance and revenue share. The Europe Mass Spectroscopy Market is Segmented by Type (Hybrid Mass Spectrometry, Single Mass Spectrometry, Other Mass Spectrometry), Application (Pharmaceutical industry, Biotechnology Industry, Chemical Industry, and Other Applications), and Geography (Germany, United Kingdom, France, Spain, Italy and Rest of Europe). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
By Technology | |||||
| |||||
| |||||
Other Mass Spectrometry |
By Application | |
Pharmaceuticals Industry | |
Biotechnology Industry | |
Chemical Industry | |
Other Applications |
Geography | |
Germany | |
United Kingdom | |
France | |
Italy | |
Spain | |
Rest of Europe |
Europe Mass Spectrometry Market Size Summary
The Europe mass spectroscopy market is poised for significant growth, driven by technological advancements and increased activity in pharmaceuticals and biotechnology. Despite the initial setbacks caused by the COVID-19 pandemic, which impacted research and development activities, the market has rebounded to pre-pandemic levels. The pandemic also highlighted the utility of mass spectroscopy in critical applications, such as COVID-19 testing, which provided a temporary boost. Key players in the market, including Agilent Technologies and Shimadzu, have been actively launching new products, such as advanced mass spectrometers, to enhance their offerings. These innovations are expected to propel the market forward, with Triple Quadrupole mass spectrometers gaining popularity due to their versatility and ease of use in various applications, including clinical diagnostics and environmental sampling.
Germany stands out as a major player in the European mass spectroscopy market, supported by substantial investments in research and development and the presence of leading market players. The country's focus on sustainable practices, as evidenced by initiatives like Thermo Fisher Scientific's IsoFootprint Project, is expected to further drive market growth. Key companies are also expanding their geographical presence through strategic acquisitions and partnerships. The market's expansion is anticipated to be fueled by high demand for advanced mass spectrometry devices and ongoing investments in pharmaceutical and biotechnology research. As a result, the European mass spectroscopy market is expected to experience robust growth over the forecast period, with Germany playing a pivotal role in this trajectory.
Europe Mass Spectrometry Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Technological Advancement
-
1.2.2 Increased Pharmaceutical and Biotechnological Compounds in Pipeline
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Instrument
-
1.3.2 Shortage of Skilled Technicians
-
-
1.4 Porter Five Forces
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Technology
-
2.1.1 Hybrid Mass Spectrometry
-
2.1.1.1 Triple Quadrupole (Tandem)
-
2.1.1.2 Quadrupole TOF (Q-TOF)
-
2.1.1.3 FTMS (Fourier Transform Mass Spectrometry)
-
-
2.1.2 Single Mass Spectrometry
-
2.1.2.1 ION Trap
-
2.1.2.2 Quadrupole
-
2.1.2.3 Time-of-flight (TOF)
-
-
2.1.3 Other Mass Spectrometry
-
-
2.2 By Application
-
2.2.1 Pharmaceuticals Industry
-
2.2.2 Biotechnology Industry
-
2.2.3 Chemical Industry
-
2.2.4 Other Applications
-
-
2.3 Geography
-
2.3.1 Germany
-
2.3.2 United Kingdom
-
2.3.3 France
-
2.3.4 Italy
-
2.3.5 Spain
-
2.3.6 Rest of Europe
-
-
Europe Mass Spectrometry Market Size FAQs
What is the current Europe Mass Spectrometry Market size?
The Europe Mass Spectrometry Market is projected to register a CAGR of 6.5% during the forecast period (2024-2029)
Who are the key players in Europe Mass Spectrometry Market?
Thermo Fisher Scientific Inc., Bruker Corporation, Waters Corporation, Dani Instruments SpA and Agilent Technologies, Inc. are the major companies operating in the Europe Mass Spectrometry Market.